Human papillomavirus integration perspective in small cell cervical carcinoma

Xiaoli Wang1,2, Wenlong Jia3, Mengyao Wang3

  • 1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P. R. China.

Nature Communications
|October 10, 2022
PubMed
Summary

Human papillomavirus (HPV) type 18 integrations are common in aggressive small cell cervical carcinoma (SCCC). These integrations activate oncogenes and form gene fusions, offering potential therapeutic targets for this lethal cancer.